D. E. Shaw & Co., Inc. Inogen Inc Transaction History

D. E. Shaw & Co., Inc.

$98.6 Billion
Q2 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Inogen Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 155,486 shares of INGN stock, worth $1.82 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

155,486

Previous 131,744 18.02%

Holding current value

$1.82 Million

Previous $1.06 Million 18.91%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$6.3 - $8.95 $149,574 - $212,490	23,742 Added 18.02%	155,486 $1.26 Million
Q1 2024 May 15, 2024	SELL	$5.26 - $10.15 $946,715 - $1.83 Million	-179,984 Reduced 57.74%	131,744 $1.06 Million
Q4 2023 Feb 14, 2024	SELL	$4.21 - $6.32 $112,705 - $169,192	-26,771 Reduced 7.91%	311,728 $1.71 Million
Q3 2023 Nov 14, 2023	BUY	$5.14 - $11.28 $185,523 - $407,140	36,094 Added 11.94%	338,499 $1.77 Million
Q2 2023 Aug 14, 2023	BUY	$10.01 - $13.86 $2.38 Million - $3.3 Million	238,030 Added 369.76%	302,405 $3.49 Million
Q1 2023 May 15, 2023	BUY	$11.88 - $26.0 $624,495 - $1.37 Million	52,567 Added 445.18%	64,375 $803,000
Q4 2022 Feb 14, 2023	BUY	$19.14 - $24.55 $23,159 - $29,705	1,210 Added 11.42%	11,808 $232,000
Q3 2022 Nov 14, 2022	BUY	$22.74 - $31.8 $240,998 - $337,016	10,598 New	10,598 $257,000
Q1 2022 May 16, 2022	SELL	$28.1 - $35.25 $169,105 - $212,134	-6,018 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$29.66 - $44.0 $10,173 - $15,092	343 Added 6.04%	6,018 $205,000
Q3 2021 Nov 15, 2021	SELL	$43.09 - $82.26 $875,674 - $1.67 Million	-20,322 Reduced 78.17%	5,675 $245,000
Q2 2021 Aug 16, 2021	BUY	$52.03 - $68.77 $751,209 - $992,901	14,438 Added 124.91%	25,997 $1.69 Million
Q1 2021 May 17, 2021	SELL	$43.96 - $55.99 $528,970 - $673,727	-12,033 Reduced 51.0%	11,559 $607,000
Q4 2020 Feb 16, 2021	SELL	$27.19 - $44.68 $633,146 - $1.04 Million	-23,286 Reduced 49.67%	23,592 $1.05 Million
Q3 2020 Nov 16, 2020	SELL	$27.01 - $37.31 $1.08 Million - $1.49 Million	-39,931 Reduced 46.0%	46,878 $1.36 Million
Q2 2020 Aug 14, 2020	SELL	$32.85 - $53.77 $4.75 Million - $7.78 Million	-144,661 Reduced 62.5%	86,809 $3.08 Million
Q1 2020 May 15, 2020	SELL	$32.63 - $67.59 $4.35 Million - $9 Million	-133,193 Reduced 36.52%	231,470 $12 Million
Q4 2019 Feb 14, 2020	BUY	$45.95 - $76.15 $14.7 Million - $24.3 Million	319,513 Added 707.67%	364,663 $24.9 Million
Q3 2019 Nov 14, 2019	BUY	$41.82 - $66.71 $1.05 Million - $1.68 Million	25,136 Added 125.59%	45,150 $2.16 Million
Q2 2019 Aug 14, 2019	SELL	$63.19 - $95.15 $1.98 Million - $2.98 Million	-31,271 Reduced 60.97%	20,014 $1.34 Million
Q1 2019 May 15, 2019	SELL	$90.12 - $152.23 $4.69 Million - $7.92 Million	-52,019 Reduced 50.36%	51,285 $4.89 Million
Q4 2018 Feb 14, 2019	BUY	$112.83 - $239.74 $11.7 Million - $24.8 Million	103,304 New	103,304 $12.8 Million

Others Institutions Holding INGN

# of Institutions

136

Shares Held

22.1M

Call Options Held

122K

Put Options Held

35.4K

View Full List

About Inogen Inc

Ticker INGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 22,866,500
Market Cap $268M
Description
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...

More about INGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account